Evidence map›Paper›PMID 38859974›Full record

ArticleFrontiers in neurology2024

Translation and validation of the Myasthenia Gravis Activities of Daily Living Questionnaire: Latvian version.

Arta Grosmane, Ieva Roze, Marija Roddate, Gundega Ķauķe, Violeta Žukova, Ieva Glāzere, Maksims Zolovs, Viktorija Ķēniņa

Abstract read
In one paragraph

Article in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Arta GrosmaneDepartment of Neurology, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.
Ieva RozeDepartment of Neurology, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.
Marija RoddateDepartment of Neurology, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.
Gundega ĶauķeDepartment of Neurology, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.
Violeta ŽukovaDepartment of Neurology, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.
Ieva GlāzereDepartment of Neurology, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.
Maksims ZolovsStatistics Unit, Rīga Stradiņš University, Riga, Latvia.
Viktorija ĶēniņaDepartment of Neurology, Pauls Stradiņš Clinical University Hospital, Riga, Latvia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Our aim was to translate, adapt and validate the Myasthenia Gravis Activities of Daily Living scale into the Latvian language and to evaluate this instrument (MG-ADL-L) in terms of construct validity and reliability. Methods: We enrolled patients with a confirmed MG diagnosis, who could speak Latvian fluently. We performed translation and adaptation according to the cross-cultural adaptation guidelines for self-reported measures. The patients were evaluated by a physician according to the Myasthenia Gravis Foundation of America classification (MGFA) and using the Myasthenia Gravis Composite Score (MGCS). Patients were asked to complete the MG-ADL-L and the 15-item Myasthenia Gravis Quality of Life (MGQOL15) Internal consistency was evaluated based on Cronbach's α, reproducibility-Cohen's weighted kappa and construct validity-Spearman's correlation between the MG-ADL-L and the MGQOL15 and MGCS. We used the Kruskal-Wallis H test to compare the MG-ADL-L score distribution between the MGFA groups. Results: 38 enrolled patients in the study. There was an acceptable internal consistency (Cronbach's α = 0.76) and moderate to very good agreement between the test and retest scores (Cohen's weighted kappa = 0.54 and 0.81). The MG-ADL-L showed a moderate positive correlation with the MGQOL15 (r = 0.5, Discussion: The MG-ADL-L is a valid and reliable self-reported scale to assess and evaluate symptom severity and the impact of the disease on the lives of patients with MG.

Indexed as

daily activitiesMG-ADLmyasthenia gravisscalevalidation

Identifiers

PMID38859974
PMCPMC11163126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.